Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
We are seeking an Associate Director, Data Product Owner – Analytics & Reporting to join our Data Solutions team reporting to the Director of Data Solutions as we prepare for commercialization. This role will serve as the product lead for analytics and BI engineering, shaping the reporting platform that delivers insights across Commercial, Market Access, Medical Affairs, and Corporate functions.
You will define the product vision and roadmap for our analytics and reporting technology, ensuring stakeholders have access to trusted, actionable insights. This role will focus on scaling our BI infrastructure, enabling automated reporting, and embedding analytics into decision-making. As a core member of the Data Solutions team, you will partner with our Analytics and Insights partners, data engineers, BI developers, external partners, and business leaders to translate requirements into robust, scalable solutions.
The ideal candidate brings experience in product management, analytics platforms, and BI tools (Tableau, Power BI, or similar), combined with an understanding of pharma commercial and medical data sources. You thrive in building first-time commercial analytics capabilities within an emerging biopharma context. In this role you will call upoin your experience to:
Define and own the technical product roadmap for the analytics and reporting platform.
Partner with stakeholders in Commercial (including Analytics and Insights, Market Access, and Sales Operations), Medical Affairs, and Finance to capture reporting needs and prioritize delivery.
Translate business requirements into user stories, technical designs, and platform specifications for developers.
Oversee the operational design and support for self-service dashboards and standardized reporting packages supporting commercial launch and beyond.
Ensure integration of industry-relevant data sources where relevant to supporting Analytics and Insights.
Provide administration support for key analytics and BI tools.
Champion data governance, visualization best practices, and reporting standards to ensure accuracy, consistency, and usability.
Collaborate with engineering to build a scalable BI and analytics infrastructure, ensuring performance, reliability, and compliance.
Promote adoption of reporting tools across functions, providing training, documentation, and support as needed.
Required Skills, Experience and Education:
Bachelor’s degree (or equivalent experience) in business, analytics, information systems, or related field.
11+ year of experiencein Product Ownership, Analytics Product Management or BI leadership roles, including 5+ years of experience in pharma/biotech.
Proven track record building analytics and BI platforms and supporting Commercial or Medical Affairs functions.
Hands-on experience with BI tools (Tableau, Power BI, Qlik, Looker) and data visualization standards.
Knowledge of key pharma commercial data sources, such as sales performance, claims, hub/patient data, CRM data, digital data, and payer coverage.
Oncology or rare disease launch experience, with knowledge of unique reporting requirements for high-touch markets.
Experience managing data and reporting vendors in an emerging pharma setting.
Comfort with SQL or data wrangling to validate reporting logic and data quality.
Strong understanding of data governance, compliance, and HIPAA requirements.
Experience with modern data platforms and warehouse technology (Databricks preferred).
Preferred Skills:
Familiarity with Agile/Scrum methodology and backlog management tools (Jira, Azure DevOps) with Agile/Scrum certification (CSPO, PSPO) or equivalent.
Experience with Omnichannel platforms, projects, and reporting needs. #LI-Hybrid #LI-YG1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
Top Skills
What We Do
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses
.png)
